Aldeyra Therapeutics to Present at MOD Live! 2022 Meeting

Aldeyra Therapeutics announced that Kelly Mizer, Aldeyra’s Vice President, Commercial Strategy and Operations, will present at the MOD Live! 2022 meeting, which will take place in Nashville, Tennessee, May 5–7, 2022.

MOD Live! 2022 is an interactive educational program that brings together optometrists and other eye care professionals to discuss new therapies and technologies, as well as best practices for patient care. Aldeyra is among several companies selected to participate in the Therapeutics Pipeline session entitled, “The Future of Optometry – Pipeline Game Changers,” which focuses on therapies and technologies in development that may have the potential to change the way optometrists manage ocular diseases. The session will run from 4:30–5:45 pm CT on Thursday, May 5.

Mr. Mizer will provide a dry eye disease program update on reproxalap, Aldeyra’s investigational new drug currently in phase 3 clinical trials for the treatment of dry eye disease and allergic conjunctivitis.